We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: PI-013
CAS No: 73024-95-0
Synonyms/Alias: Met-enkephalin-Arg-Phe;73024-95-0;Tyr-gly-gly-phe-met-arg-phe;Yggfmrf;Met-enk-AP;Enkephalin met, heptapeptide;6-Arg-7-phe-met-enkephalin;Met-enkephalin, arg(6)-phe(7)-;enkephalin-Met, Arg(6)-Phe(7)-;Methionine-enkephalin, arg(6)-phe(7)-;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoic acid;Enkephalin-met, arginyl(6)-phenylalanine(7)-;Methionine-enkephalin-arginine-phenylalanine;Tyrosyl-glycyl-glycyl-phenylalanyl-methionyl-arginyl-phenylalanine;L-Phenylalanine, N-(N(2)-(N-(N-(N-(N-L-tyrosylglycyl)glycyl)-L-phenylalanyl)-l-methionyl)-L-arginyl)-;MEAP peptide;MERF peptide;H-Tyr-Gly-Gly-Phe-Met-Arg-Phe-OH;MFCD00076425;CHEBI:80265;HY-P4196;DA-55364;FM108789;PD150438;CS-0647109;H-Tyr-Gly-Gly-Phe-Met-Arg-Phe-OH; H-YGGFMRF-OH;Met-Enkephalin-Arg-Phe (H-L-Tyr-Gly-Gly-L-Phe-L-Met-L-Arg-L-Phe-OH);(2S,5S,8S,11S,20S)-20-amino-2,11-dibenzyl-5-(3-guanidinopropyl)-21-(4-hydroxyphenyl)-8-(2-(methylthio)ethyl)-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazahenicosan-1-oic acid;
Chemical Name: (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C42H56N10O9S |
M.W/Mr. | 877 |
Sequence | One Letter Code:YGGFMRF Three Letter Code:H-Tyr-Gly-Gly-Phe-Met-Arg-Phe-OH |
InChI | InChI=1S/C42H56N10O9S/c1-62-20-18-32(39(58)50-31(13-8-19-46-42(44)45)38(57)52-34(41(60)61)23-27-11-6-3-7-12-27)51-40(59)33(22-26-9-4-2-5-10-26)49-36(55)25-47-35(54)24-48-37(56)30(43)21-28-14-16-29(53)17-15-28/h2-7,9-12,14-17,30-34,53H,8,13,18-25,43H2,1H3,(H,47,54)(H,48,56)(H,49,55)(H,50,58)(H,51,59)(H,52,57)(H,60,61)(H4,44,45,46)/t30-,31-,32-,33-,34-/m0/s1 |
InChI Key | KTQKWSPZOZKAEE-LJADHVKFSA-N |
Canonical SMILES | CSCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N |
Isomeric SMILES | CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)[C@H](CC3=CC=C(C=C3)O)N |
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com